Table of Contents Pharma news – 9 July 2020 Mylan gears up to sell its generic version of Remdesivir at 4,800 rupees in India: Cipla and Hetero labs began the sale of their generic version of Remdesivir in India in June 2020. Hetero priced its generic version, Covifor at 5,400 rupees. Cipla however claimed that […]
Pharma News – 9 July 2020 Updates Read More »
Indian Government is reviewing the use of Remdesivir for Covid-19 following reports of liver damage The Union Health Ministry of India is currently reviewing the use of Remdesivir in the country. Multiple reports of liver damage in the Covid-19 patients treated with this drug have instigated this action. The side-effects of Remdesivir was one of
Pharma news – 5 July 2020 Read More »
1. Hindustan Antibiotic’s moves to explore opportunities in line with self-reliant India Around 70% of the active pharmaceutical ingredients (API) needed for the production of important drugs in India are imported from China. However, the current volatility between the two countries has instilled fear and uncertainty in the minds of everyone. To reduce this dependency,
Pharma News – 28 June 2020 Read More »
India plans to reduce the import of API and other raw materials from China The military face-off between India and China has put both the countries in a frenzy. To prevent things from escalating downhill, both countries have resorted to talking things out smoothly. But despite this, precautionary measures are being adopted from both sides
Pharma news – 25 June 2020 Read More »
USFDA revokes the special status given to Hydroxychloroquine for treating Covid-19 In March 2020, the US[1] president, Donald Trump began to advocate the use of Hydroxychloroquine and azithromycin for treating Covid-19. His persuasive speech backed up by his claim of taking Hydroxychloroquine regularly won the trust of the entire country. This subsequently increased the demand
Pharma News – 18 June 2020 Read More »
Remdesivir receives approval from the Indian government Gilead Sciences antiviral drug, Remdesivir has grabbed the attention of many countries for its ability to treat Covid-19. It was granted the emergency use authorization by the USFDA[1] in April,2020. The Japanese health regulators have also approved the use of Remdesivir in Covid-19 patients. On 1 June,2020 this
Pharma news – 4 June,2020 Read More »
